EAPH.US Easton Pharmaceutica

Healthcare Pharmaceuticals USA Stocks
0.0000 USD
Close of May 15, 2026
Market cap
USD 26.9K
P/E
-
P/B
0.00x
ROE
-5.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2021.

Is EAPH.US undervalued?

Graham number

The Graham number of Easton Pharmaceutica cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Easton Pharmaceutica fundamental analysis

No fundamental analysis for Easton Pharmaceutica yet.

Easton Pharmaceutica stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Easton Pharmaceutica

Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. It focuses on development, licenses, production, and markets prescription and over-the-counter products. The company was formerly known as Easton Pharmaceuticals Inc. and changed its name to Parallel Industries Inc. in December 2020. Parallel…

Full company profile